Skip to content
RESEARCH REFERENCE · 10 MG VIAL

ARA-290 protocol & vial guide

Cibinetide / EPO-derived 11-residue peptide

ARA-290 (cibinetide) is an investigational EPO-derived peptide with limited, supervised human research in selected neuropathy populations. Both listed research suppliers sell a 10 mg vial, which is not a licensed medicine.

Research summary · not a validated human regimen. Research supplier products are not approved for injection or treatment.
01

ARA-290 · vial at a glance

CompoundARA-290
Labelled vial / kit content10 mg
Evidence categoryPreliminary / limited validation
Illustrative volume in existing datasetNot specified

A vial size describes labelled content, not a dose. The example volume above is arithmetic context only; it is not a verified diluent choice or preparation instruction for a supplier product.

Peak Peptides Australia ARA-290 10 mg vialExact-match Peak Peptides vial image
02

Reported schedule and evidence context

Catalogue research example · human regimen not established

The rows below come from the site's previously catalogued research summary. They have not been established as a validated clinical schedule for this formulation. Route, amount, escalation and timing may differ across published experiments; do not use the rows as instructions for human or animal administration.

No validated human schedule is available for this compound. The published preclinical experiment must not be converted into personal administration directions.

For research-only formulations, a separate licensed medicine or study does not validate a human regimen for the supplier vial. Clinical decisions require a qualified professional and the correct licensed product.

03

Preparation: what to verify first

There is no single diluent, mixing method or storage period suitable for every peptide. Follow the exact formulation's qualified instructions instead of applying this chart to a different vial.

01

Confirm vial identity

Check the compound, labelled quantity, lot, seal, expiry and certificate or insert before planning any calculation.

02

Check the specified diluent

Use only the formulation-specific diluent and volume supported by the product instructions. Bacteriostatic water is not universally compatible.

03

Check the resulting solution

Use the labelled mixing and inspection method. Stop if an intended clear solution is cloudy, particulate, discoloured or otherwise abnormal.

04

Document and store

Record the product, volume and date, then use its validated storage and discard period. Do not infer a universal shelf life.

Open the illustrated reconstitution guide
04

Concentration and volume calculator

Keep mass and volume separate

Concentration = labelled mass ÷ final liquid volume. A U-100 marking measures liquid volume (100 markings = 1 mL), not a peptide amount or an International Unit of activity.

The calculator checks arithmetic. It does not select a dose, establish compatibility or validate a research product for injection.

No formulation-specific mixing volume and dose are established for this entry. The standalone calculator can check arithmetic only after the inputs have been independently verified.
Open full calculator
05

Evidence, handling and limitations

Research mechanism

Investigational tissue-protection signalling investigated in preclinical and small human studies; clinical benefit has not been established for these vials.

Handling and storage

Storage temperature, light protection, diluent compatibility and discard period must be confirmed for the precise formulation and lot. Do not carry a shelf life from an approved pen or another compound to a research vial.

For research purposes only. ARA-290 vial reference: a reported trial or catalogue schedule is not a prescription. Research-only supplier vials are not approved medicines; validate any preparation with the exact formulation documentation. No clinical benefit or safety claim is implied for research-only material.

06

Research suppliers and product identity

Open the specific product page to confirm current vial strength, formulation, batch documentation and legal use category. A supplier listing does not make a research reagent an approved medicine.

Peak Peptides Australia and Pure Performance Australia links are independently tracked in the site analytics.

07

References and related reading

Sources

No source bibliography is attached to this older catalogue record. Interpret any reported schedule as unverified until primary evidence is reviewed.